𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Loss of heterozygosity at 11q23.1 and survival in breast cancer: Results of a large European study

✍ Scribed by Kirsten Laake; Virpi Launonen; Dieter Niederacher; Sigfridur Gudlaugsdottir; Susanne Seitz; Pascale Rio; Marie-Hélène Champème; Ivan Bièche; Daniel Birnbaum; Gavin White; Marianna Sztan; Natasa Sever; Sarah Plummer; Ana Osorio; Annegien Broeks; Pia Huusko; Nigel Spurr; Åke Borg; Anne-Marie Cleton-Jansen; Laura van't Veer; Javier Benitez; Graham Casey; Borut Peterlin; Edith Olah; Jenny Varley; Yves-Jean Bignon; Siegfried Scherneck; Valgerdur Sigurdardottir; Rosette Lidereau; Jorunn Eyfjord; Matthias Wilhelm Beckmann; Robert Winqvist; Eva Skovlund; Anne-Lise Børresen-Dale

Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
237 KB
Volume
25
Category
Article
ISSN
1045-2257

No coin nor oath required. For personal study only.

✦ Synopsis

Among the chromosomal regions commonly undergoing deletions in breast tumors is 11q23.1. The genes that are targets for loss of heterozygosity (LOH) in this region is not yet established. One of the candidate genes located in this region is ATM, responsible for the rare autosomal recessive disorder ataxia-telangiectasia (A-T). Interestingly, A-T heterozygotes may have an increased risk of cancer, in particular breast cancer, although this is still controversial. A common assumption has been that the target for the LOH at 11q23.1 in breast carcinoma is the ATM gene, but the area studied has been too large, the density of markers too low, and the number of tumors studied has been too small to draw any firm conclusions. The present study is a multicenter study including 918 breast cancer patients with clinical information and survival data available for most of them. Primary breast tumors were investigated for LOH using a high density of microsatellite markers spanning approximately 6 Mb around the ATM gene. Survival analyses showed that there are most likely one or more candidate genes in a 3-4 Mb region between the markers D11S1819 and D11S927 including the ATM gene. Cancer-specific survival was significantly reduced in patients whose tumors exhibited LOH of markers D11S2179 (within the ATM gene), D11S1778, D11S1294, and D11S1818. The highest survival hazard ratios were 1.8 (CI 1.2-2.8, P ϭ 0.010) and 2.1 (CI 1.4-3.0, P ϭ 0.0004) for markers D11S2179 and D11S1818, respectively. One or more of these markers are therefore most likely to be located close to or within genes associated with breast cancer survival.

📜 SIMILAR VOLUMES

Loss of heterozygosity at 11q23.1 in bre
Loss of heterozygosity at 11q23.1 in breast carcinomas: Indication for involvement of a gene distal and close to ATM
✍ Kirsten Laake; Åse Ødegård; Tone Ikdahl Andersen; Ida K. Bukholm; Rolf Kåresen; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB 👁 1 views

Previous reports have suggested that heterozygotes for ataxia-telangiectasia (A-T) have an increased risk of cancer, in particular breast cancer. The ATM gene, responsible for A-T, was recently cloned. Loss of heterozygosity (LOH) in the chromosome band 11q23, where the ATM gene is located, has been

Linkage analysis and loss of heterozygos
Linkage analysis and loss of heterozygosity for chromosome arm 1p in familial breast cancer
✍ Robert C. Millikan; Sue A. Ingles; Anh T. Diep; Shanyan Xue; Nianmin Zhou; Barba 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB 👁 1 views

We conducted linkage analysis of 64 multiple-case families with early-onset bilateral breast cancer using DNA markers on chromosome band 1p36. Evidence against tight linkage was obtained using a dominant model for transmission (summary LOD scores at recombination fraction ϭ 0.000001 were -4.71 for D

Loss of heterozygosity at the TP53 gene:
Loss of heterozygosity at the TP53 gene: Independent occurrence from genetic instability events in node-negative breast cancer
✍ Sarab Lizard-Nacol; Jean-Marc Riedinger; Gérard Lizard; Anne-Lise Glasser; Nolwe 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 84 KB 👁 1 views

TP53 abnormalities have been reported as an early event in the process of cellular transformation of human breast cancers, and involved in mammary-tumor evolution, from in situ to invasive disease. In this study, node-negative (N-) tumors were examined for TP53 allelic loss in relation to different

Loss of heterozygosity and lack of mutat
Loss of heterozygosity and lack of mutations of theXPG/ERCC5 DNA repair gene at 13q33 in prostate cancer
✍ Hyytinen, Eija-Riitta; Frierson, Henry F.; Sipe, Tavis W.; Li, Chang-Ling; Degeo 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 268 KB 👁 2 views

BACKGROUND. Three regions of chromosome 13 were previously identified for having loss of heterozygosity (LOH) in human prostate cancer. One of them, at 13q33, was defined by LOH at markers D13S158 and D13S280. The XPG/ERCC5 gene, a DNA repair gene that when mutated in the germline leads to xeroderma